<DOC>
	<DOC>NCT01960881</DOC>
	<brief_summary>Canadian Real Life Evaluation of the Effect of Diet and Exercise in Prostate Cancer Patients Managed with Lupron.</brief_summary>
	<brief_title>Evaluation of Diet and Exercise in Prostate Cancer Patients</brief_title>
	<detailed_description>This is a study utilizing a prospective cohort design. Patients with Prostrate cancer (PCa) who are prescribed Lupron will be entered into the study cohort and will be followed for a maximum of 36 months with recommended assessments at 3, 6, 12, 18, 24, 30 and 36 months after Day 1. Treatment of the patients and follow up will be according to the physicians' judgment, regional regulations and the product monograph.</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>i. Adult â‰¥ 18 years old ii. Has provided written informed consent allowing the use of their data for the study and providing permission for contact by the study personnel. iii. Diagnosed with PCa. iv. Prescribed Lupron as part of his treatment by his treating physician. i. Patient cannot or will not sign informed consent. ii. Presence of other condition that, in the opinion of the treating physician, prohibits the patient from participating in the study or obscures the assessment of the treatment of PCa. iii. Survival expectancy less than 23 years as per the treating physician judgment iv. No longer than 6 months of therapy if currently on Luteinizing hormonereleasing hormone (LHRH) agonist treatment.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Prostate cancer</keyword>
</DOC>